Navigation Links
Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
Date:1/3/2008

the Study Co-ordinating Center for both trials. Approximately 50 sites will be recruited for the trial in patients undergoing cardiac surgery and 35 sites for the colorectal surgery trial.

The cardiac surgery trial will enroll diabetic and/or obese (BMI>30) patients known to be at a higher risk of sternal wound infections, a serious and potentially life-threatening complication of cardiac surgery. The trial design is based upon a published 2,000 patient clinical trial demonstrating that the implant significantly reduced the incidence of sternal wound infection (SWI) by 53% when used as an adjunct to standard infection prophylaxis. This was a prospective, randomized, controlled clinical study performed at two hospital centers in Sweden and led by Dr. Orjan Friberg, Cardiothoracic Surgeon at Orebro University Hospital. Patients in the treatment group had two Gentamicin Implants (260 mg total dose) placed between the sternal halves before closure. The primary endpoint (total incidence of SWIs after 2 months post-surgery) was 9.0% in the control group and 4.3% in the treatment group (p<0.001). Sub-population analysis of known high-risk groups showed even greater treatment effect; including a 68% reduction in infection from 17.3% in the control group to 5.6% in the treatment group for patients with diabetes. Using the data generated in this cardiac surgery trial, a health economic analysis was performed and published showing that routine prophylactic use of the Gentamicin Implant resulted in a net cost saving per patient.

The design of the second trial in patients undergoing colorectal surgery is based upon an approved and well established use of GETAMICIN SURGICAL IMPLANT for this indication in Europe. Several such studies have been published, including one prospective, randomized, controlled clinical trial in 221 patients which demonstrated a 70% decrease in surgical site infections from 18.4% in the control group to 5.6% in the patients treated with the
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Va. , Nov. 21, 2014  Alta Home ... Southern California , today announced a ... Alta will be providing the innovative BeClose system to ... Logo - http://photos.prnewswire.com/prnh/20141121/160143LOGO ... the kind of affordable 24/7 care our clients need ...
(Date:11/21/2014)... 2014  World Hemp Oil, an importer of oil ... are now offering legal, organic oil with high CBD ... grown in medical marijuana states. People suffering from epileptic ... Parkinson,s, MS, and spinal cord injury, no longer have ... imported CBD Oil Is legal in all states. ...
(Date:11/21/2014)... , 21. November 2014 /PRNewswire/ ... hat heute bekannt gegeben, dass die ... EMA) die Kennzeichnung als Orphan-Medizinprodukt an ... des Unternehmens zur Behandlung von Fibrodysplasia ... seltene, stark beeinträchtigende genetische Krankheit, die ...
Breaking Medicine Technology:Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
... new study, published in the Journal of Medicinal ... 8 grams (1/3 ounce) of "Sun Chlorella A" daily ... total cholesterol, and fasting blood glucose levels.For a 12-week ... A" tablets each morning and evening. Seventeen subjects ...
... Global Laboratory,s Technology Transfer Expertise to Support Biomarker ... have become increasingly important to Alzheimer,s disease research ... testing new therapies and eventual early intervention with ... part of its ongoing research and development of ...
Cached Medicine Technology:First Human Study to Show 'Sun Chlorella A' Supports Heart Health 2BARC Central Laboratory Joins Alzheimer's Association Research Roundtable 2BARC Central Laboratory Joins Alzheimer's Association Research Roundtable 3
(Date:11/22/2014)... Recently, UWDress.com, a successful wedding dress shop, has released ... in order to prepare for the wedding season. All of ... , UWDress.com is a reliable company that has many ... new items -- formal wedding guest attire. This new collection ... superstar and princess. As one of the leading companies in ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding dresses, ... business offers a wide range of special occasion dresses, ... them to create multiple looks easily. , According to ... of chic wedding dresses has been prepared for many ... rates now. Dylan Queen can always create what ladies ...
(Date:11/22/2014)... order to provide better services, LunaDress has updated its website ... knows that a suitable cocktail party dress is crucial for ... party dresses supplier’s high quality items are offered at attracting ... fashion industry, LunaDress understands that it is not easy to ... raises the professional level and innovation ability. The growth of ...
(Date:11/22/2014)... November 22, 2014 Domestic farmgate ... slightly in 2009-10, due to a fall in ... industry products amid the global financial crisis. ... strength of Australian dairy manufacturers on the international ... products outweighed supply growth, primarily due to supply ...
(Date:11/22/2014)... has been a historical time for Angeldress.co.uk, an excellent wedding ... some renowned review websites. Recently, the company has added to ... of wonderful sexy wedding dresses to its website. At the ... to an 80% discount on any order over GBP 149. ... dress at Angeldress.co.uk, which has garnered a hard core of ...
Breaking Medicine News(10 mins):Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2
... E. Lachman has been awarded a $1.45 million five-year ... more about factors that can minimize memory declines in ... beliefs and behaviors that are tied to better memory ... and older adults believe that memory declines are inevitable ...
... Jobson Medical Information LLC,("JMI"), a leading ... it has acquired Gerber Communications ("Gerber") and,Practice ... leading,providers of custom publishing services and training ... acquisition expands JMI,s ability to,reach eye care ...
... Medical Center today,announced the use of an investigational, ... treatment of heart rhythm,disorders that can result in ... first performed in Texas as part of the ... taking place at up,to 25 hospitals throughout the ...
... other systemic uses of drugs to ... growth factor (VEGF), BOSTON, Feb. 13 New research ... the anti-cancer drug Avastin,which targets a growth factor responsible for ... certain patients.,Institute scientists mimicked the drug,s activity in mice and ...
... speech,pathologist and autism consultant Valerie Herskowitz will present ... the "Autism Through,the Lifespan" conference to be held ... now for an entire generation of children challenged ... and becoming young,adults with autism. Technology is the ...
... MALVERN, Pa., Feb. 13 A new study ... medical expenses reported,by auto injury claimants continue to ... economic losses (which include expenses for,medical care, lost ... claimants grew 9 percent annualized, from $5,520 in ...
Cached Medicine News:Health News:Brandeis researcher awarded grant to investigate memory and aging 2Health News:Jobson Medical Information LLC Acquires Gerber Communications and Practice Advancement Associates 2Health News:St. David's Medical Center First in Texas to Implement Visually Guided Catheter Ablation for Atrial Fibrillation 2Health News:VEGF Neutralization Can Damage Brain Vessels, Say Schepens Eye Research Institute Scientists 2Health News:A Sneak Peek Into the Special Needs Home of Tomorrow - Renowned Autism Consultant Valerie Herskowitz to Present Latest Findings at 'Autism Through the Lifespan' Conference February 14-17 in Orlando 2Health News:IRC Reports Claimed Medical Expenses for Auto Injury Claimants Far Outpace Inflation 2
... were developed in surgeon's desire to have ... an instrument with the strength to maneuver ... the bending or breaking. Arthrotek Hand Instruments ... to the surgeon's hand. This new generation ...
... Arthrotek® Precision Hand Instruments were developed ... tactile feel, while still having an instrument ... spaces without the fear of the bending ... designed and manufactured to conform to the ...
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
... were developed in surgeon's desire to have ... an instrument with the strength to maneuver ... the bending or breaking. Arthrotek Hand Instruments ... to the surgeon's hand. This new generation ...
Medicine Products: